Cargando…

A spotlight on alkaloid nanoformulations for the treatment of lung cancer

Numerous naturally available phytochemicals have potential anti-cancer activities due to their vast structural diversity. Alkaloids have been extensively used in cancer treatment, especially lung cancers, among the plant-based compounds. However, their utilization is limited by their poor solubility...

Descripción completa

Detalles Bibliográficos
Autores principales: S. M., Sindhoor, Naveen, N. Raghavendra, Rao, GSN Koteswara, Gopan, Gopika, Chopra, Hitesh, Park, Moon Nyeo, Alshahrani, Mohammed Merae, Jose, Jobin, Emran, Talha Bin, Kim, Bonglee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623325/
https://www.ncbi.nlm.nih.gov/pubmed/36330493
http://dx.doi.org/10.3389/fonc.2022.994155
_version_ 1784821973506850816
author S. M., Sindhoor
Naveen, N. Raghavendra
Rao, GSN Koteswara
Gopan, Gopika
Chopra, Hitesh
Park, Moon Nyeo
Alshahrani, Mohammed Merae
Jose, Jobin
Emran, Talha Bin
Kim, Bonglee
author_facet S. M., Sindhoor
Naveen, N. Raghavendra
Rao, GSN Koteswara
Gopan, Gopika
Chopra, Hitesh
Park, Moon Nyeo
Alshahrani, Mohammed Merae
Jose, Jobin
Emran, Talha Bin
Kim, Bonglee
author_sort S. M., Sindhoor
collection PubMed
description Numerous naturally available phytochemicals have potential anti-cancer activities due to their vast structural diversity. Alkaloids have been extensively used in cancer treatment, especially lung cancers, among the plant-based compounds. However, their utilization is limited by their poor solubility, low bioavailability, and inadequacies such as lack of specificity to cancer cells and indiscriminate distribution in the tissues. Incorporating the alkaloids into nanoformulations can overcome the said limitations paving the way for effective delivery of the alkaloids to the site of action in sufficient concentrations, which is crucial in tumor targeting. Our review attempts to assess whether alkaloid nanoformulation can be an effective tool in lung cancer therapy. The mechanism of action of each alkaloid having potential is explored in great detail in the review. In general, Alkaloids suppress oncogenesis by modulating several signaling pathways involved in multiplication, cell cycle, and metastasis, making them significant component of many clinical anti-cancerous agents. The review also explores the future prospects of alkaloid nanoformulation in lung cancer. So, in conclusion, alkaloid based nanoformulation will emerge as a potential gamechanger in treating lung cancer in the near future.
format Online
Article
Text
id pubmed-9623325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96233252022-11-02 A spotlight on alkaloid nanoformulations for the treatment of lung cancer S. M., Sindhoor Naveen, N. Raghavendra Rao, GSN Koteswara Gopan, Gopika Chopra, Hitesh Park, Moon Nyeo Alshahrani, Mohammed Merae Jose, Jobin Emran, Talha Bin Kim, Bonglee Front Oncol Oncology Numerous naturally available phytochemicals have potential anti-cancer activities due to their vast structural diversity. Alkaloids have been extensively used in cancer treatment, especially lung cancers, among the plant-based compounds. However, their utilization is limited by their poor solubility, low bioavailability, and inadequacies such as lack of specificity to cancer cells and indiscriminate distribution in the tissues. Incorporating the alkaloids into nanoformulations can overcome the said limitations paving the way for effective delivery of the alkaloids to the site of action in sufficient concentrations, which is crucial in tumor targeting. Our review attempts to assess whether alkaloid nanoformulation can be an effective tool in lung cancer therapy. The mechanism of action of each alkaloid having potential is explored in great detail in the review. In general, Alkaloids suppress oncogenesis by modulating several signaling pathways involved in multiplication, cell cycle, and metastasis, making them significant component of many clinical anti-cancerous agents. The review also explores the future prospects of alkaloid nanoformulation in lung cancer. So, in conclusion, alkaloid based nanoformulation will emerge as a potential gamechanger in treating lung cancer in the near future. Frontiers Media S.A. 2022-10-18 /pmc/articles/PMC9623325/ /pubmed/36330493 http://dx.doi.org/10.3389/fonc.2022.994155 Text en Copyright © 2022 S. M., Naveen, Rao, Gopan, Chopra, Park, Alshahrani, Jose, Emran and Kim https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
S. M., Sindhoor
Naveen, N. Raghavendra
Rao, GSN Koteswara
Gopan, Gopika
Chopra, Hitesh
Park, Moon Nyeo
Alshahrani, Mohammed Merae
Jose, Jobin
Emran, Talha Bin
Kim, Bonglee
A spotlight on alkaloid nanoformulations for the treatment of lung cancer
title A spotlight on alkaloid nanoformulations for the treatment of lung cancer
title_full A spotlight on alkaloid nanoformulations for the treatment of lung cancer
title_fullStr A spotlight on alkaloid nanoformulations for the treatment of lung cancer
title_full_unstemmed A spotlight on alkaloid nanoformulations for the treatment of lung cancer
title_short A spotlight on alkaloid nanoformulations for the treatment of lung cancer
title_sort spotlight on alkaloid nanoformulations for the treatment of lung cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623325/
https://www.ncbi.nlm.nih.gov/pubmed/36330493
http://dx.doi.org/10.3389/fonc.2022.994155
work_keys_str_mv AT smsindhoor aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT naveennraghavendra aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT raogsnkoteswara aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT gopangopika aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT choprahitesh aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT parkmoonnyeo aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT alshahranimohammedmerae aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT josejobin aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT emrantalhabin aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT kimbonglee aspotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT smsindhoor spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT naveennraghavendra spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT raogsnkoteswara spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT gopangopika spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT choprahitesh spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT parkmoonnyeo spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT alshahranimohammedmerae spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT josejobin spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT emrantalhabin spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer
AT kimbonglee spotlightonalkaloidnanoformulationsforthetreatmentoflungcancer